Literature DB >> 13841112

Evidence of allergy in patients with cystic fibrosis of the pancreas.

T E VAN METRE, R E COOKE, L E GIBSON, W L WINKENWERDER.   

Abstract

Entities:  

Keywords:  ALLERGY/complications; PANCREATIC CYSTIC FIBROSIS/complications

Mesh:

Year:  1960        PMID: 13841112     DOI: 10.1016/0021-8707(60)90037-x

Source DB:  PubMed          Journal:  J Allergy        ISSN: 0021-8707


× No keyword cloud information.
  9 in total

1.  Significance of fibrocystic disease in adults.

Authors:  A I MENDELOFF
Journal:  Am J Dig Dis       Date:  1961-05

Review 2.  Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.

Authors:  S P Conway; A Watson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Cell mediated immunity and suppressor T cell function in children with cystic fibrosis.

Authors:  T B Harper; H R Gaumer; W Waring; R B Brannon; J E Salvaggio
Journal:  Lung       Date:  1980       Impact factor: 2.584

Review 4.  Immunological abnormalities in cystic fibrosis: chicken or egg?

Authors:  M E Hodson
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

5.  Atopy and bronchial reactivity in older patients with cystic fibrosis.

Authors:  M J Tobin; O Maguire; D Reen; E Tempany; M X Fitzgerald
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

6.  Association of cystic fibrosis with allergy.

Authors:  J O Warner; B W Taylor; A P Norman; J F Soothill
Journal:  Arch Dis Child       Date:  1976-07       Impact factor: 3.791

Review 7.  The relationship between atopy and cystic fibrosis.

Authors:  R W Wilmott
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

8.  Cystic fibrosis, atopy, and airways lability.

Authors:  M Silverman; F D Hobbs; I R Gordon; F Carswell
Journal:  Arch Dis Child       Date:  1978-11       Impact factor: 3.791

9.  Reversible airway obstruction in cystic fibrosis.

Authors:  L P Ormerod; R A Thomson; C M Anderson; D E Stableforth
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.